Cefic: Enforce Counterfeit Drug Rules

The European Commission says it has received about 100 submissions from pharma firms and patient groups, under the commission’s consultation exercise to determine how best to curb the production of counterfeit medicines. Cefic sent a submission saying that effective enforcement of existing legislation could significantly improve the current situation. “If properly enforced with severe penalties for offenders, [legislation] would significantly reduce the escalating risk driven by globalization and hyper-competition in off-patent medicines,” Cefic...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers